CDRD VENTURES INC has a total of 16 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2015. It filed its patents most often in Australia, Brazil and Israel. Its main competitors in its focus markets pharmaceuticals and biotechnology are IBC PHARMACEUTICALS INC, KS BIOMEDIX LTD and IMCLONE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Brazil | 2 | |
#3 | Israel | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Russian Federation | 1 | |
#11 | United States | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hsieh Tom Han Hsiao | 9 |
#2 | Jaquith James Brian | 8 |
#3 | Arns Stephen Paul | 8 |
#4 | Liggins Richard Tom | 8 |
#5 | Simonson Eric Roy | 8 |
#6 | Kumar Nag Sharwan | 8 |
#7 | Baudelet Davy Jérémy | 4 |
#8 | Baudelet Davy Jeremy | 4 |
#9 | Nag Sharwan Kumar | 3 |
#10 | Eric Roy Simonson | 3 |
Publication | Filing date | Title |
---|---|---|
CN109104863A | Somatostatin receptor antagonist compound and its application method |